LTRN

Lantern Pharma (LTRN)

About Lantern Pharma (LTRN)

Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184. The company was founded by Arun K. Asaithambi, Gregory T. Tobin, and Peter L. Nara on November 7, 2013 and is headquartered in Dallas, TX.

Details

Daily high

$3.47

Daily low

$3.25

Price at open

$3.36

52 Week High

$6.12

52 Week Low

$2.55

Market cap

36.5M

Dividend yield

0.00%

Volume

40,116

Avg. volume

72,913

P/E ratio

-1.86

Lantern Pharma News